The global defibrillator market is expected to reach USD 21.92 billion by 2025, according to a new report by Grand View Research, Inc. To increase the availability of these products in developed countries, the government is making amendments in their policies to make the product available at various places.
The healthcare expenditure at a global level is rising, along with increasing penetration of public and private health insurance. This rise is expected to fuel demand for defibrillators across various end-user segments.
In the U.S., there are more than 250,000 cases of death due to SCA every year. In order to, decrease this number, all the 50 states have enforced or supported the broad public access law. The American Heart Association noted that a minimum of 20,000 lives were saved due to publicly accessible defibrillators annually. It is also estimated that as many as 50,000 deaths are prevented due to deployment of AEDs among the trained responders. The states recommend that Public Access Defibrillators (PADs) must be present in public buildings, transportation centers, residential apartments and transportation centers.
Defibrillator market is driven by innovative processes. For instance, a program under trial in Sweden is likely to deliver AEDs via drones. This is anticipated to reduce the delivery time for defibrillators, thus saving more lives. The growth of this industry can be attributed to new product development, mergers & acquisitions, and rising market penetration.
To request a sample copy or view summary of this report, click the link below:
Further Key Findings From the Study Suggest:
Implantable Convertible Defibrillator (ICD) was the major contributor in this industry in 2016
External defibrillators recorded the fastest growth in the industry
Hospitals were the major contributors in the end-use segment in 2016
The public access market was the fastest growing end-user segment of the overall industry in 2016
North America held a major share in this industry
Asia Pacific region is anticipated to exhibit fastest growth in the global defibrillator industry
Some of the key players are Medtronic; St. Jude Medical LLC; Boston Scientific Corporation; LivaNova; Koninklijke Philips N.V.; ZOLL Medical Corporation; Cardiac Science; Physio-Control Inc.; Nihon Kohden Corporation; Defibtech LLC; HeartSine Technologies LLC; Progetti Srl; Fukuda Denshi Co., Ltd.; and Schiller AG
New product development, mergers & acquisitions, and regional expansion are some of the strategic initiatives undertaken by the key players
Grand View Research has segmented the defibrillator market by product, end user, and region:
Defibrillator Product Outlook (Revenue, USD Million; 2014 - 2025)
Implantable Cardioverter Defibrillator
External Defibrillator (ED)
Wearable Cardioverter Defibrillator
Defibrillator End-Use Outlook (Revenue, USD Million; 2014 - 2025)
Public Access Market
Alternate Care Market
Defibrillator Regional Outlook (Revenue, USD Million; 2014 - 2025)
Avail customized purchase options to meet your research needs:
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.